Back
Range Oncology Therapeutics ETF Vs. PTC Therapeutics Industry Stock Comparison
Sell
38
CNCR
Range Oncology Therapeutics ETF
Last Price:
13.51
Seasonality Move:
-0.68%
Sell
35
PTCT
PTC Therapeutics
Last Price:
31.30
Seasonality Move:
8.27%
Sell
38
Range Oncology Therapeutics ETF (CNCR)
is a Sell
Is Range Oncology Therapeutics ETF a Buy, Sell or Hold?
- The current Range Oncology Therapeutics ETF [CNCR] share price is $13.51. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.58. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Oncology Therapeutics ETF's stock price today?
-
The Range Oncology Therapeutics ETF share price today is $13.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 36.54 | Sell |
Chaikin Money Flow: | 5426 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.84 - 14.7) | Sell |
Bollinger Bands (100): | (14.35 - 16.41) | Sell |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 34.74 | Sell |
Chaikin Money Flow: | 26543 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.49 - 37.71) | Sell |
Bollinger Bands (100): | (26.63 - 35.17) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.73 | Sell |
20-day SMA: | 14.22 | Sell |
50-day SMA: | 14.61 | Sell |
200-day SMA: | 13.53 | Sell |
8-day EMA: | 13.77 | Sell |
20-day EMA: | 14.11 | Sell |
50-day EMA: | 14.56 | Sell |
200-day EMA: | 14.21 | Sell |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.57 | Sell |
20-day SMA: | 36.04 | Sell |
50-day SMA: | 33.78 | Sell |
200-day SMA: | 27.65 | Buy |
8-day EMA: | 34.28 | Sell |
20-day EMA: | 35.15 | Sell |
50-day EMA: | 33.95 | Sell |
200-day EMA: | 31.82 | Sell |
Range Oncology Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
Range Oncology Therapeutics ETF Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |